ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
Published 7 months ago • 79 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
1:59
the efficacy of venetoclax-based salvage therapy in patients with previously treated r/r aml
-
13:23
ven-based salvage followed by ven and dli maintenance vs. flag-ida for r/r aml post-asct
-
2:18
ven-aza versus intensive chemotherapy as bridging therapy in patients with mds
-
2:34
new salvage treatment for aml/mds after allogeneic transplant: the viola trial
-
2:50
insights into the ca057-003 trial: mezigdomide, tazemetostat & dexamethasone for r/r myeloma
-
1:13
bisantrene for r/r aml patients
-
6:44
the current landscape for the treatment of r/r aml in the post-transplant setting
-
1:12
hma in combination with venetoclax and magrolimab in the treatment of aml
-
9:25
mgus diagnosis: a step-by-step approach
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:33
the role of bispecific antibodies in the treatment of patients with multiple myeloma
-
3:33
len/aza seems effective as a novel salvage therapy for post-transplant relapsed aml: viola results
-
1:20
flt3 inhibitors as mrd-guided salvage treatment for molecular failure in flt3-mutated aml
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
2:34
the evolution of the aml treatment paradigm
-
1:40
tag-aza-ven in the treatment of patients with newly diagnosed cd123 aml
-
2:11
efficacy of parp inhibitors in the treatment of aml
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
1:11
the treatment of aml within the united kingdom nhs framework
-
1:19
new treatments for aml
-
4:54
aml treatment: ash 2020 and beyond
-
2:19
maintaining remission in aml and improving long-term survival in patients who do not receive hsct